- US-listed companies
- Kiromic Biopharma, Inc.
- Balance sheet
Kiromic Biopharma, Inc. (KRBPQ) Balance sheet
Market cap
$153.33
P/E ratio
| 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Cash and cash equivalents | 10 | 25 | 1 | 3 | 2 |
| Total cash & short-term investments | 10 | 25 | 1 | 3 | 2 |
| Accounts receivable, net | - | 16,200 | - | - | - |
| Total current assets | 11 | 27 | 2 | 4 | 3 |
| Property, plant and equipment, net | 2 | 4 | 8 | 6 | 4 |
| Total non-current assets | 2 | 4 | 10 | 8 | 5 |
| Total assets | 13 | 31 | 12 | 12 | 9 |
| Accounts payable | 665,200 | 2 | 7 | 2 | 3 |
| Total current liabilities | 1 | 3 | 13 | 20 | 21 |
| Total non-current liabilities | - | - | 4 | 1 | 0 |
| Total liabilities | 1 | 3 | 18 | 21 | 21 |
| Common stock and paid-in capital | 53 | 95 | 96 | 114 | 137 |
| Retained earnings | -42 | -67 | -102 | -123 | -150 |
| Stockholders' equity | 11 | 27 | -6 | -9 | -13 |